MRUS vs. APLT

In the year-to-date period, MRUS achieves a 52.18% return, which is significantly higher than APLT's -73.73% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Merus N.V. (MRUS) and Applied Therapeutics, Inc. (APLT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current MRUS Sharpe Ratio is 1.06, which is higher than the APLT Sharpe Ratio of -0.47. The chart below compares the historical Sharpe Ratios of MRUS and APLT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither MRUS nor APLT has paid dividends to shareholders.

The maximum MRUS drawdown since its inception was -67.42%, smaller than the maximum APLT drawdown of -99.03%. Use the drawdown chart below to compare losses from any high point for MRUS and APLT. For additional features, visit the drawdowns tool.

The current volatility for Merus N.V. (MRUS) is 15.15%, while Applied Therapeutics, Inc. (APLT) has a volatility of 143.03%. This indicates that MRUS experiences smaller price fluctuations and is considered to be less risky than APLT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Merus N.V. and Applied Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.